Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
Status:
Not yet recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This proposed study aims to evaluate the efficacy of daily Cannabidiol (CBD) Oil Capsules in
treating symptoms of DSM-5 anxiety disorders, using a two-arm, 8-week randomized,
placebo-controlled trial in adults aged 21-65 years. The study will also evaluate the
relationship between inflammation, anxiety and CBD using biological markers as well as
examine the neuro-cognitive effects of CBD treatment.